Viewing nowCombinationTelmisartan/Rosuvastatin 40/20 Milligrams
Telmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.

MFDS item code 201907248 · Approved 2019.10.15 · Insurance code 657806790
Treatment of hypertension, improvement of dyslipidemia, and inhibition of cardiovascular disease risk and progression
This medicine contains two components: Telmisartan and Rosuvastatin, which are used together only in patients who need both. Telmisartan is mainly used for patients with essential hypertension and helps to lower the risk of myocardial infarction, stroke, and cardiovascular death in elderly patients or those with diabetes who are at high cardiovascular risk. Rosuvastatin is mainly used when cholesterol levels cannot be controlled by diet, particularly in patients with familial hypercholesterolemia or mixed dyslipidemia, and it lowers blood cholesterol levels and slows the progression of atherosclerosis. Additionally, Rosuvastatin reduces the risk of cardiovascular diseases, as well as the risks associated with stroke, myocardial infarction, and revascularization procedures. This medicine is used to manage hypertension and dyslipidemia simultaneously and improve cardiovascular health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan/rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after treatment is started. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Ethnicity: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.
This medicine can cause serious harm to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Individuals allergic to this medicine or its components, pregnant women, or breastfeeding women should not take it. Patients with severe liver or kidney impairment, or a history of certain muscle diseases or angioedema should also avoid using this medicine. Elderly patients, those with hyperkalemia, and those with liver impairment must use caution when taking this medicine, and liver enzyme levels and kidney function should be regularly monitored. If symptoms such as muscle pain, weakness, or cramps occur, consult a physician immediately, and, if necessary, a blood test should be performed to check for muscle damage. This medicine may interact with other blood pressure medications, diuretics, potassium supplements, etc., so it is essential to inform healthcare professionals about all other medications being taken. If symptoms of liver dysfunction, allergic reactions, angioedema, severe dizziness, or hypotension occur, discontinue use immediately and consult healthcare professionals. This medicine may cause drowsiness or dizziness while driving or operating machinery, so caution is necessary. Store this medicine out of reach of children and do not transfer it to another container.
Headache, orthostatic dizziness, sleep paralysis, increased blood pressure, decreased blood pressure, hypotension, elevated ALT, dysuria, rhinitis, discomfort in oropharynx, lung disease, gastrointestinal disorders, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual abnormalities, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, abnormal liver function, liver dysfunction, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, elevated serum creatinine, elevated serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, angioedema, hypovolemia, angioedema associated with hypersensitivity reaction, diabetes, constipation, nausea, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, arrhythmia, facial spasms, sensory disturbances, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, appetite loss, edema, decreased libido, facial edema, alopecia, conjunctivitis, buzzing in the ears, petechiae, palpitations, fatigue, nausea, inadequate effect, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This ensures the effectiveness of the medication remains safe.
White oval film-coated tablet
30 tablets/box [10 tablets/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.